Nasdaq tells KaloBios its chapter 11 filing is further grounds for d...

12/31/15

Nasdaq tells KaloBios its chapter 11 filing is further grounds for delisting ...
MarketWatch
KaloBios Pharmaceuticals Inc. KBIO, -5.09% the company recently taken over by controversial biotech investor Martin Shkreli, said Thursday it has received notice from the Nasdaq exchange that its Chapter 11 bankruptcy filing Wednesday is additional ...